Oncology

Krzysztof’s story

 “I had ignored the symptoms for a long time but finally I couldn’t manage them anymore. I was diagnosed with colorectal cancer. During my illness, my appetite was gone. I was 74kg when I went into hospital – it was so scary.

I saw a leaflet in the hospital about medical nutrition, so my wife asked the nurse about it. The nurse said it could help. The increase in my appetite was a breakthrough. I soon began to eat normally again. The increase of appetite restored my love for life.”

“The increase of appetite restored my love for life.”

Krzysztof - Poland

Increase in cancer incidence

A cancer diagnosis is a life-changing event for both patients and the people around them. For many reasons, the incidence of cancer is expected to rise over the coming years. An aging population, urbanization, a decrease in exercise, obesity and smoking all contribute to the increase in numbers.

Why do cancer patients lose weight?

One of the most common physical changes experienced by cancer patients is weight loss; in fact, it can be one of the first signs that something is wrong. One in three patients is likely to lose weight at some point during their illness3. There are lots of reasons for this, including reduced food intake due to poor appetite, nausea or swallowing problems, as well as metabolic changes caused by the disease itself and/or its treatment.

The link between undernutrition and recovery ('clinical outcomes') is well established. For example, a lower body mass index (BMI) can reduce the effectiveness of cancer treatment, leading to higher hospital readmission rates and often a lower quality of life.

Find out more

Nutricia’s role in oncology

Nutricia works hard to make a positive and proven difference to patients' lives, by supporting patients, carers and societies throughout their journey with cancer and helping to deliver a better quality of life. We do so by collaborating with societies like ESSO (European Society for Surgical Oncology), ESMO (The European Society for Medical Oncology), ESPEN (European Society for Parental and Enteral Nutrition), hospitals and cancer patients.


Our Oncology products

The Nutricia products shown from this point onwards are intended for the nutritional management of diseases and related medical conditions and therefore should be used under medical supervision.

  1. Cancer Research UK 071219.
  2. LavianoA et al. Nutrition 1996;12: p.358-71.
  3. Pressoir et al, 2010 Br J Cancer. 16;102(6):966-71 

 

Taste alterations

Up to 70% of cancer patients experience a change in the way they taste food, often as a result of their treatment. Find out more about this often-overlooked issue and how it can affect nutritional intake in cancer patients.

Find out more

Malnutrition

Cancer-related malnutrition and loss of lean body mass (‘cachexia’) are common and associated with poor outcomes for the patient. Find out more about the causes and consequences, as well as the aim of nutritional interventions

Find out more

Consequences of weight loss during cancer

Weight loss can affect the success of treatment [4]. At Danone Nutricia Research, we work with cancer specialists, academic institutions, as well as cancer patients themselves, in order to develop nutritional solutions that address patients’ needs.